Stem Cell Therapy for Chronic Pain Management: Review of Uses, Advances, and Adverse Effects.

@article{Chakravarthy2017StemCT,
  title={Stem Cell Therapy for Chronic Pain Management: Review of Uses, Advances, and Adverse Effects.},
  author={Krishnan V. Chakravarthy and Yian Chen and Cathy He and Paul J. Christo},
  journal={Pain physician},
  year={2017},
  volume={20 4},
  pages={
          293-305
        }
}
BACKGROUND This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. [] Key MethodSTUDY DESIGN Narrative review. METHODS The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www.clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: "chronic pain," "disc pain," "cell therapy," "osteoarthritis…

Tables from this paper

Stem Cell Therapy and Its Significance in Pain Management
TLDR
The role of stem cells in the pain management of neuropathic, discogenic back, osteoarthritis, and musculoskeletal pain is discussed, along with the mechanism, adverse effects, and risks of stem cell therapy.
What is new in pain modification in osteoarthritis?
There is a big need for the development of novel therapies for the safe management of chronic pain associated with OA. Here we reviewed PubMed (2015 onward) and ClinicalTrials.gov for ongoing and
Status of N-of-1 Trials in Chronic Pain Management: A Narrative Review
TLDR
Results confirmed that N-of-1 trials have solved the refractory cases including osteoarthritis, chronic musculoskeletal pain, and neuropathic pain; however, none of the trials dealt with cancer pain.
Regenerative Therapies for Chronic Intradiscal Pain
TLDR
Intradiscal injection of mesenchymal stem cell products and platelet-rich plasma is being studied increasingly by pain physicians as a novel therapy for the treatment of discogenic pain.
Stem cell therapy in pain medicine
TLDR
The main idea of applying stem cell transplantation to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathicPain.
Progress with stem cell therapies for tendon tissue regeneration
TLDR
The role of a variety of regenerative medicine options to induce and favor regeneration and healing of tendon tissue, focusing on the role of mesenchymal stem cell therapy and their derivatives is discussed.
Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study
TLDR
Initial evidence of safety and efficacy of ADMSCs for discogenic LBP is provided, with MRI demonstrated no further disc degeneration and improvements to annular fissures and disc protrusions.
Pain and Neuropathic Pain in Rheumatic Diseases
TLDR
It has been proposed that a chronic pain stimulus may have a greater impact in a chronic inflammatory state, and the process towards a pain condition may be influenced by individual predisposition for development of chronic pain.
...
1
2
3
...

References

SHOWING 1-10 OF 53 REFERENCES
Adult Stem Cell as New Advanced Therapy for Experimental Neuropathic Pain Treatment
TLDR
The overall positive results obtained on pain remission by using stem cells that are safe, of easy isolation, and which may allow an autologous transplant in patients may be encouraging for moving from bench to bedside, although there are several issues that still need to be solved.
Mesenchymal stem cell therapy for osteoarthritis: current perspectives
TLDR
Current state of MSC-based therapeutics for OA is summarized and potential barriers that must be overcome are discussed for successful implementation of cell-based therapy as a routine treatment strategy in orthopedics.
A preliminary report on stem cell therapy for neuropathic pain in humans
TLDR
This preliminary open-labeled study showed autologous administration of stem cells for neuropathic trigeminal pain significantly reduced pain intensity at 6 months and is a safe and well tolerated intervention.
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells: A Pilot Study
TLDR
Assessment of the feasibility and safety of osteoarthritis treatment with mesenchymal stromal cells in humans found the intervention is simple, does not require hospitalization or surgery, provides pain relief, and significantly improves cartilage quality.
Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain.
TLDR
Clinical outcomes indicated that HUC-MSC transplantation is a favorable alternative method for the treatment of chronic discogenic low back pain.
Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial
TLDR
Allogeneic MSC therapy may be a valid alternative for the treatment of chronic knee osteoarthritis that is more logistically convenient than autologous MSC treatment and significantly improves cartilage quality.
Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study
TLDR
MSC therapy may be a valid alternative treatment for chronic back pain caused by degenerative disc disease andvantages over current gold standards include simpler and more conservative intervention without surgery, preservation of normal biomechanics, and same or better pain relief.
Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells.
TLDR
The described process of autologous mesenchymal stem cell culture and percutaneous injection into a knee with symptomatic and radiographic degenerative joint disease resulted in significant cartilage growth, decreased pain and increased joint mobility in this patient, which has significant future implications for minimally invasive treatment of osteoarthritis and meniscal injury.
Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients
TLDR
This data indicates that suppression of pro‐inflammatory cytokines and metalloproteinases in MSC patients with Osteoarthritis is a major cause of disease progression and the use of MSCs for treatment is warranted.
...
1
2
3
4
5
...